News Release

WARSAW – Zimmer Biomet has announced an exclusive, multi-year co-marketing agreement with Surgical Planning that will allow the orthopedic company to venture into mixed-reality navigation for select hip surgeries.

The agreement with Surgical Planning Associates focuses on the commercialization of its HipInsight, which is the first FDA-cleared, mixed-reality navigation system for total hip replacement. It is customized for Zimmer Biomet’s hip implant portfolio, according to a news release.

It allows surgeons to use Microsoft HoloLens 2 glasses to visualize a hologram of the patient’s pelvic anatomy during surgery.

Zimmer Biomet said that HipInsight expands the capabilities of its ZBEdge suite of integrated smart, digital and robotic technologies. The company added HipInsight to its OptiVu mixed reality portfolio of applications.

“The addition of HipInsight to our mixed reality portfolio advances our commitment to transform the surgical experience with the latest innovative technologies to help surgeons improve accuracy, strive for better outcomes and optimize efficiency during total hip arthroplasty,” said Dr. Nitin Goyal, chief science, technology and innovation officer at Zimmer Biomet. “This collaboration enables us to offer surgeons a sophisticated and proven mixed reality-based visualization tool customized for exclusive use with our hip implant portfolio.”

The use of mixed-reality glasses and a smart registration tool overlays holograms in real-time during surgery. This gives the surgeon a direct view of the surgical plan over the patient’s anatomy.

“We’re proud to partner with Zimmer Biomet, a leader in joint arthroplasty, to co-market HipInsight for their portfolio of hip implant systems,” said Dr. Stephen B. Murphy, founder of Surgical Planning Associates.